Pundarik Bhat serves as a Principal Research Scientist and CMC Lead for Engineering Operations at AbbVie, where he plays a pivotal role in the lifecycle management of Injectable Dermal Fillers within the AbbVie-Allergan Aesthetics portfolio. With over 20 years of experience in R&D Engineering, Pundarik...
Pundarik Bhat serves as a Principal Research Scientist and CMC Lead for Engineering Operations at AbbVie, where he plays a pivotal role in the lifecycle management of Injectable Dermal Fillers within the AbbVie-Allergan Aesthetics portfolio. With over 20 years of experience in R&D Engineering, Pundarik has honed his expertise in product design and development, particularly in the medical device sector. His extensive background encompasses more than 15 years dedicated to the research and launch of innovative medical devices and drug-device combination products, making him a key asset in navigating the complexities of the industry.
At AbbVie, Pundarik is responsible for overseeing the Chemistry, Manufacturing, and Control (CMC) processes, ensuring that products not only meet rigorous FDA standards but also align with the strategic goals of the organization. His leadership in managing the lifecycle of Injectable Dermal Fillers, which command a remarkable $1.5 billion market share, underscores his ability to drive projects from conception through to successful market introduction. Pundarik employs advanced methodologies such as Failure Mode and Effects Analysis (FMEA) and utilizes tools like Minitab and SolidWorks to enhance product reliability and performance.
His proficiency in injection molding and a deep understanding of regulatory compliance further bolster his capability to lead cross-functional teams in delivering high-quality medical devices. Pundarik's commitment to innovation and excellence in the medical device field not only contributes to the success of AbbVie’s product offerings but also enhances patient outcomes globally, reflecting his dedication to advancing healthcare technology.
